Interferon-Î³ blockade in CAR T-cell therapy-associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis.

Rainone, Michael; Ngo, Dat; Baird, John H; Budde, L Elizabeth; Htut, Myo; Aldoss, Ibrahim; Pullarkat, Vinod

Rainone, Michael; Ngo, Dat; Baird, John H; Budde, L Elizabeth; Htut, Myo; Aldoss, Ibrahim; Pullarkat, Vinod.

Afiliación

Rainone M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Ngo D; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Baird JH; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Budde LE; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Htut M; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.
Pullarkat V; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA.

Blood Adv ; 7(4): 533-536, 2023 02 28.

Article en En | MEDLINE | ID: mdl-35917457

Asunto(s)

Linfohistiocitosis Hemofagocítica; Síndrome de Activación Macrofágica; Humanos; Linfohistiocitosis Hemofagocítica/etiología; Linfohistiocitosis Hemofagocítica/terapia; Síndrome de Activación Macrofágica/diagnóstico; Síndrome de Activación Macrofágica/etiología; Síndrome de Activación Macrofágica/terapia; Interferón gamma; Inmunoterapia Adoptiva/efectos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfohistiocitosis Hemofagocítica / Síndrome de Activación Macrofágica Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google